HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(3-nitrobenzoyl)alanine

inhibits kynurenine hydroxylase; structure in first source

Also Known As:

(m-nitrobenzoyl)alanine; m-nitrobenzoylalanine

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Alanine: 4133
    - (3-nitrobenzoyl)alanine: 1

Related Diseases

1.	Brain Ischemia (Cerebral Ischemia) 07/01/1999 - "Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia."
2.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/01/1999 - "Two kynurenine hydroxylase inhibitors, (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfona mide (Ro 61-8048), have been tested as neuroprotective agents on brain lesions induced by bilateral carotid occlusion in gerbils or by middle cerebral artery occlusion in rats. "

Related Drugs and Biologics

1.	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)
2.	Benzenesulfonamides
3.	Neuroprotective Agents